Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation

Sho Kanzaki, Timo Stöver, Kohei Kawamoto, Diane M. Prieskorn, Richard A. Altschuler, Josef M. Miller, Yehoash Raphael

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

As with other cranial nerves and many CNS neurons, primary auditory neurons degenerate as a consequence of loss of input from their target cells, the inner hair cells (IHCs). Electrical stimulation (ES) of spiral ganglion cells (SGCs) has been shown to enhance their survival. Glial cell line-derived neurotrophic factor (GDNF) has also been shown to increase survival of SGCs following IHC loss. In this study, the combined effects of the GDNF transgene delivered by adenoviral vectors (Ad-GDNF) and ES were tested on SGCs after first eliminating the IHCs. Animal groups received Ad-GDNF or ES or both. Ad-GDNF was inoculated into the cochlea of guinea pigs after deafening, to overexpress human GDNF. ES-treated animals were implanted with a cochlear implant electrode and chronically stimulated. A third group of animals received both Ad-GDNF and ES (GDNF/ES). Electrically evoked auditory brainstem responses were recorded from ES-treated animals at the start and end of the stimulation period. Animals were sacrificed 43 days after deafening and their ears prepared for evaluation of IHC survival and SGC counts. Treated ears exhibited significantly greater SGC survival than nontreated ears. The GDNF/ES combination provided significantly better preservation of SGC density than either treatment alone. Insofar as ES parameters were optimized for maximal protection (saturated effect), the further augmentation of the protection by GDNF suggests that the mechanisms of GDNF- and ES-mediated SGC protection are, at least in part, independent. We suggest that GDNF/ES combined treatment in cochlear implant recipients will improve auditory perception. These findings may have implications for the prevention and treatment of other neurodegenerative processes.

Original languageEnglish
Pages (from-to)350-360
Number of pages11
JournalJournal of Comparative Neurology
Volume454
Issue number3
DOIs
Publication statusPublished - 2002 Dec 16

Fingerprint

Glial Cell Line-Derived Neurotrophic Factor
Nerve Degeneration
Denervation
Electric Stimulation
Spiral Ganglion
Inner Auditory Hair Cells
Ear
Cochlear Implants
Cell Survival
Cell Count
Auditory Perception
Neurons
Cytoprotection
Brain Stem Auditory Evoked Potentials
Cranial Nerves
Cochlea
Alopecia
Transgenes
Electrodes
Guinea Pigs

Keywords

  • Cochlea
  • Cochlear implant
  • Gene transfer
  • Growth factors
  • Guinea pig
  • Spiral ganglion

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. / Kanzaki, Sho; Stöver, Timo; Kawamoto, Kohei; Prieskorn, Diane M.; Altschuler, Richard A.; Miller, Josef M.; Raphael, Yehoash.

In: Journal of Comparative Neurology, Vol. 454, No. 3, 16.12.2002, p. 350-360.

Research output: Contribution to journalArticle

Kanzaki, Sho ; Stöver, Timo ; Kawamoto, Kohei ; Prieskorn, Diane M. ; Altschuler, Richard A. ; Miller, Josef M. ; Raphael, Yehoash. / Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. In: Journal of Comparative Neurology. 2002 ; Vol. 454, No. 3. pp. 350-360.
@article{d28161c3e2c34bffb631dff754921bb7,
title = "Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation",
abstract = "As with other cranial nerves and many CNS neurons, primary auditory neurons degenerate as a consequence of loss of input from their target cells, the inner hair cells (IHCs). Electrical stimulation (ES) of spiral ganglion cells (SGCs) has been shown to enhance their survival. Glial cell line-derived neurotrophic factor (GDNF) has also been shown to increase survival of SGCs following IHC loss. In this study, the combined effects of the GDNF transgene delivered by adenoviral vectors (Ad-GDNF) and ES were tested on SGCs after first eliminating the IHCs. Animal groups received Ad-GDNF or ES or both. Ad-GDNF was inoculated into the cochlea of guinea pigs after deafening, to overexpress human GDNF. ES-treated animals were implanted with a cochlear implant electrode and chronically stimulated. A third group of animals received both Ad-GDNF and ES (GDNF/ES). Electrically evoked auditory brainstem responses were recorded from ES-treated animals at the start and end of the stimulation period. Animals were sacrificed 43 days after deafening and their ears prepared for evaluation of IHC survival and SGC counts. Treated ears exhibited significantly greater SGC survival than nontreated ears. The GDNF/ES combination provided significantly better preservation of SGC density than either treatment alone. Insofar as ES parameters were optimized for maximal protection (saturated effect), the further augmentation of the protection by GDNF suggests that the mechanisms of GDNF- and ES-mediated SGC protection are, at least in part, independent. We suggest that GDNF/ES combined treatment in cochlear implant recipients will improve auditory perception. These findings may have implications for the prevention and treatment of other neurodegenerative processes.",
keywords = "Cochlea, Cochlear implant, Gene transfer, Growth factors, Guinea pig, Spiral ganglion",
author = "Sho Kanzaki and Timo St{\"o}ver and Kohei Kawamoto and Prieskorn, {Diane M.} and Altschuler, {Richard A.} and Miller, {Josef M.} and Yehoash Raphael",
year = "2002",
month = "12",
day = "16",
doi = "10.1002/cne.10480",
language = "English",
volume = "454",
pages = "350--360",
journal = "Journal of Comparative Neurology",
issn = "0021-9967",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation

AU - Kanzaki, Sho

AU - Stöver, Timo

AU - Kawamoto, Kohei

AU - Prieskorn, Diane M.

AU - Altschuler, Richard A.

AU - Miller, Josef M.

AU - Raphael, Yehoash

PY - 2002/12/16

Y1 - 2002/12/16

N2 - As with other cranial nerves and many CNS neurons, primary auditory neurons degenerate as a consequence of loss of input from their target cells, the inner hair cells (IHCs). Electrical stimulation (ES) of spiral ganglion cells (SGCs) has been shown to enhance their survival. Glial cell line-derived neurotrophic factor (GDNF) has also been shown to increase survival of SGCs following IHC loss. In this study, the combined effects of the GDNF transgene delivered by adenoviral vectors (Ad-GDNF) and ES were tested on SGCs after first eliminating the IHCs. Animal groups received Ad-GDNF or ES or both. Ad-GDNF was inoculated into the cochlea of guinea pigs after deafening, to overexpress human GDNF. ES-treated animals were implanted with a cochlear implant electrode and chronically stimulated. A third group of animals received both Ad-GDNF and ES (GDNF/ES). Electrically evoked auditory brainstem responses were recorded from ES-treated animals at the start and end of the stimulation period. Animals were sacrificed 43 days after deafening and their ears prepared for evaluation of IHC survival and SGC counts. Treated ears exhibited significantly greater SGC survival than nontreated ears. The GDNF/ES combination provided significantly better preservation of SGC density than either treatment alone. Insofar as ES parameters were optimized for maximal protection (saturated effect), the further augmentation of the protection by GDNF suggests that the mechanisms of GDNF- and ES-mediated SGC protection are, at least in part, independent. We suggest that GDNF/ES combined treatment in cochlear implant recipients will improve auditory perception. These findings may have implications for the prevention and treatment of other neurodegenerative processes.

AB - As with other cranial nerves and many CNS neurons, primary auditory neurons degenerate as a consequence of loss of input from their target cells, the inner hair cells (IHCs). Electrical stimulation (ES) of spiral ganglion cells (SGCs) has been shown to enhance their survival. Glial cell line-derived neurotrophic factor (GDNF) has also been shown to increase survival of SGCs following IHC loss. In this study, the combined effects of the GDNF transgene delivered by adenoviral vectors (Ad-GDNF) and ES were tested on SGCs after first eliminating the IHCs. Animal groups received Ad-GDNF or ES or both. Ad-GDNF was inoculated into the cochlea of guinea pigs after deafening, to overexpress human GDNF. ES-treated animals were implanted with a cochlear implant electrode and chronically stimulated. A third group of animals received both Ad-GDNF and ES (GDNF/ES). Electrically evoked auditory brainstem responses were recorded from ES-treated animals at the start and end of the stimulation period. Animals were sacrificed 43 days after deafening and their ears prepared for evaluation of IHC survival and SGC counts. Treated ears exhibited significantly greater SGC survival than nontreated ears. The GDNF/ES combination provided significantly better preservation of SGC density than either treatment alone. Insofar as ES parameters were optimized for maximal protection (saturated effect), the further augmentation of the protection by GDNF suggests that the mechanisms of GDNF- and ES-mediated SGC protection are, at least in part, independent. We suggest that GDNF/ES combined treatment in cochlear implant recipients will improve auditory perception. These findings may have implications for the prevention and treatment of other neurodegenerative processes.

KW - Cochlea

KW - Cochlear implant

KW - Gene transfer

KW - Growth factors

KW - Guinea pig

KW - Spiral ganglion

UR - http://www.scopus.com/inward/record.url?scp=0037121752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037121752&partnerID=8YFLogxK

U2 - 10.1002/cne.10480

DO - 10.1002/cne.10480

M3 - Article

C2 - 12442325

AN - SCOPUS:0037121752

VL - 454

SP - 350

EP - 360

JO - Journal of Comparative Neurology

JF - Journal of Comparative Neurology

SN - 0021-9967

IS - 3

ER -